RxDoctor Payments Data

Byron Baptist, MD

Internal Medicine · Saint Louis, MONPI 1518253699

Payments from drug & device makers

$2,808in general payments, 2019–2025

Across 182 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$354
  • AbbVie$263
  • GSK$246
  • Novo Nordisk$236
  • Astellas Pharma US Inc$220
  • Lilly USA, LLC$181
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,61793%
  • Education$1917%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,808 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$134,719
Medicare patients
375
Services billed
1,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban150$153,370
FarxigaDapagliflozin Propanediol94$99,274
OzempicSemaglutide67$93,826
JardianceEmpagliflozin60$72,179
MounjaroTirzepatide48$61,193
TrulicityDulaglutide54$54,949
RybelsusSemaglutide32$35,758
XareltoRivaroxaban28$33,913
JanuviaSitagliptin Phosphate19$20,023
LinzessLinaclotide33$19,567
Repatha SureclickEvolocumab33$19,544
MyrbetriqMirabegron18$15,689
ArexvyRsvpref3 Antigen/As01e/Pf64$15,171
LivaloPitavastatin Calcium25$13,576
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$9,840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$354$160,499184 claims
Novo NordiskOzempic, Rybelsus$236$129,58399 claims
Lilly USA, LLCMounjaro, Trulicity$181$116,142102 claims
AstraZenecaFarxiga, Symbicort$87$103,916106 claims
Johnson & JohnsonXarelto$95$33,91328 claims
GSKArexvy, Anoro Ellipta$246$25,01185 claims
MerckJanuvia$17$20,02319 claims
AbbVieLinzess$263$19,56733 claims
Astellas Pharma US IncMyrbetriq$220$15,68918 claims
Kowa Pharmaceuticals America, Inc.Livalo$84$13,57625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,097 internal medicine providers in Missouri.

Other internal medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →